Rubedo Life Science Company

Rubedo Life Sciences mission is to treat age-related diseases to extend health-span targeting senescence and stem cells. Powered by their drug discovery computational platform ALEMBIC™ and enabled by their proprietary chemistry engineering, Rubedo makes novel drugs designed to be selective, safe and well tolerated. Rubedo’s lead small molecules are engineered to be selectively activated in pathological cells that drive age-related diseases.
Industry: Small&Large Molecules
Headquarters: Sunnyvale, California, United States

Visit Website
Register and Claim Ownership